Clinical Trial Update: Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update for Hexadecasaccharide SR123781A in patients with unstable angina or Non-ST-segment elevation myocardial infarction that has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Non-st-segment Elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Hexadecasaccharide SR123781A

Snippet

Sponsor: Sanofi | Conditions: Coronary Atherosclerosis | Phase 2 | Status: COMPLETED